Literature DB >> 17342456

[Selective immunoadsorption in neurologic complications of systemic lupus erythematosus].

S Harscher1, S Rummler, P Oelzner, H-J Mentzel, M Brodhun, O W Witte, C Terborg, S Isenmann.   

Abstract

Vasculitis of the nervous system is a rare cause of multifocal neurologic symptoms and may involve both the central and peripheral nervous systems. Typical symptoms include headache, encephalopathy with cognitive impairment and psychotic symptoms, epileptic seizures, and peripheral neuropathies. Here we report the case of a 71-year-old female presenting with Raynaud's syndrome and paresthesia of the feet. Several weeks later she was admitted to our hospital with a status epilepticus and complex partial seizures. On admission she had mild aphasia, distal paresis of the arms without sensory deficits, and disorientation with hallucinations. Cerebral MRI revealed small, multifocal infarctions in several arterial territories. Multiple cerebral artery stenoses were detected by ultrasound. Examination of the CSF was unremarkable. Serologic tests for autoimmune disorders detected Ro antibodies compatible with systemic lupus erythematosus or Sjögren's syndrome. A sural nerve biopsy revealed ischemic axonal neuropathy. During administration of i.v. methylprednisolone, the symptom progression stopped but dosages could not be tapered due to severe CNS symptoms (mental decline, disorientation, aphasia, hallucinations). Slow but sustained clinical improvement was achieved by immunoadsorption over 3 weeks followed by a combined high-dose immunosuppressive treatment with cyclophosphamide and prednisolone that paralleled a reduction in anti-Ro titers and normalization of cerebral blood flow velocities as detected by repeated transcranial Doppler sonography. Systemic vasculitis may present with multiple neurologic and psychiatric symptoms due to involvement of the central and peripheral nervous systems. After excluding systemic infection, immunosuppressive therapy should be started early. In our case a combination of high-dose methylprednisolone, immunoadsorption with elimination of Ro antibodies, and cyclophosphamide led to the patient's recovery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17342456     DOI: 10.1007/s00115-006-2252-2

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  11 in total

Review 1.  [Cerebral vasculitis].

Authors:  P Berlit
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

Review 2.  [Aggressive therapy of highly active systemic lupus erythematosus].

Authors:  W Graninger
Journal:  Acta Med Austriaca       Date:  1996

3.  Treatment of systemic lupus erythematosus by immunoadsorption in a patient suffering from tuberculosis.

Authors:  Sabine Schmaldienst; Martin Jansen; Ursula Hollenstein; Winfried Graninger; Heinz Regele; Walter Hermann Hörl; Kurt Derfler
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

4.  Neuropsychiatric manifestations of systemic lupus erythematosus.

Authors:  H G Bluestein
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

5.  Therapeutic plasma exchange and cyclosporine in the treatment of systemic lupus erythematosus.

Authors:  R Schiel; R Bambauer
Journal:  Ther Apher       Date:  1999-08

Review 6.  Immunoadsorption in Guillain-Barré syndrome and myasthenia gravis.

Authors:  W F Haupt; F Rosenow; C van der Ven; C Birkmann
Journal:  Ther Apher       Date:  2000-06

7.  [A case of severe neuropsychiatric lupus erythematosus treated by plasmapheresis: diagnostic values of serum antiribosomal P protein antibodies and interleukin-6 in cerebrospinal fluid].

Authors:  W Fukui; H Sano; T Tanabe; T Ueda; S Hirohata; A Hashiramoto; R Yamada; H Kato; M Kondo
Journal:  Nihon Rinsho Meneki Gakkai Kaishi       Date:  1998-08

8.  The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus.

Authors:  C Michael Neuwelt
Journal:  Ther Apher Dial       Date:  2003-04       Impact factor: 1.762

Review 9.  Vasculitis of the central nervous system.

Authors:  J M Ferro
Journal:  J Neurol       Date:  1998-12       Impact factor: 4.849

10.  Treatment of myasthenia gravis by immunoadsorption of plasma.

Authors:  D Grob; D Simpson; H Mitsumoto; B Hoch; F Mokhtarian; A Bender; M Greenberg; A Koo; S Nakayama
Journal:  Neurology       Date:  1995-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.